科研製薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4521/E00935KAKEN PHARMACEUTICAL CO., LTD.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2017/04/28日証協無担保4,000株+400%0株0%1,400株0%
2017/04/28日証協有担保109,523株+30.88%9,996株-53.73%43,200株+59.41%
2017/04/21日証協無担保800株0%0株-100%0株-100%
2017/04/21日証協有担保83,681株-19.84%21,603株+146.13%27,100株-37.27%
2017/04/14日証協無担保0株0%1,300株-96.62%100株-98.94%
2017/04/14日証協有担保104,394株+123.38%8,777株-81.1%43,200株-52.49%
2017/04/07日証協無担保0株-100%38,500株0%9,408株-6.43%
2017/04/07日証協有担保46,733株-6.81%46,439株+173.3%90,920株-47.96%
2017/03/31日証協無担保1,400株0%0株-100%10,054株+3251.33%
2017/03/31日証協有担保50,147株+170.82%16,992株+18.65%174,700株+204.27%
2017/03/24日証協無担保1,400株0%27,273株-35.56%300株-94.23%
2017/03/24日証協有担保18,517株-26.75%14,321株-76.25%57,417株+76.65%
2017/03/17日証協無担保0株-100%42,325株0%5,200株+5100%
2017/03/17日証協有担保25,278株+94.34%60,300株+337.18%32,504株-48.72%
2017/03/10日証協無担保1,100株-56%0株0%100株-51.69%
2017/03/10日証協有担保13,007株-88.35%13,793株-70.29%63,382株-31.26%
2017/03/03日証協無担保2,500株-68.75%0株0%207株-74.12%
2017/03/03日証協有担保111,640株+185.99%46,418株+563.11%92,200株+98.71%
2017/02/24日証協無担保8,000株-31.62%0株0%800株-84.35%
2017/02/24日証協有担保39,036株+34.14%7,000株-77.4%46,400株-7.75%
2017/02/17日証協有担保29,100株-3.44%30,979株-43.24%50,300株-0.95%
2017/02/10日証協無担保11,700株0%0株0%5,111株+135.53%
2017/02/10日証協有担保30,136株+324.45%54,576株-0.41%50,784株+226.21%
2017/02/03日証協無担保0株0%0株0%2,170株-57.47%
2017/02/03日証協有担保7,100株-84.4%54,800株+1204.76%15,568株-60.16%
2017/01/27日証協無担保0株-100%0株0%5,102株+537.75%
2017/01/27日証協有担保45,500株-63.39%4,200株-91.8%39,074株-37.48%
2017/01/20日証協無担保15,300株+70%0株0%800株-73.33%
2017/01/20日証協有担保124,295株+231.71%51,200株+0.2%62,500株-35.1%
2017/01/13日証協無担保9,000株+1185.71%0株0%3,000株+2464.1%
2017/01/13日証協有担保37,471株-62.21%51,100株+55.32%96,300株+179.94%
2017/01/06日証協無担保700株-99.4%0株0%117株-90.25%
2017/01/06日証協有担保99,146株+93.06%32,900株+396.83%34,400株-84.56%
2016/12/30日証協無担保117,600株+9999.99%0株0%1,200株+1100%
2016/12/30日証協有担保51,356株+116.69%6,622株-63.81%222,820株+618.77%
2016/12/22日証協無担保300株-99.02%0株0%100株-91.72%
2016/12/22日証協有担保23,700株-70.92%18,300株-13.27%31,000株-64.33%

※株式分割は考慮していませんのでご注意ください。

Page Top